Anti-atherosclerotic effect of glinide or sulfonylurea in Japanese patients with type 2 diabetes mellitus

Anti-atherosclerotic effect of glinide or sulfonylurea in Japanese patients with type 2 diabetes mellitus - Anti-atherosclerotic effect of glinide or sulfonylurea in Japanese patients with type 2 diabetes mellitus

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010467

Enrollment

30

Registered

2013-04-11

Start date

2006-01-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes mellitus

Interventions

glinide sulfonylurea

Sponsors

Division of Cardiovascular Medicine, Endocrinology and Metabolism, Department of Molecular Medicine and Therapeutics, Tottori University Faculty of Medicine

Lead Sponsor

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: HbA1c>6.5%

Exclusion criteria

Exclusion criteria: Renal failure, Liver dysfunction

Design outcomes

Primary

Measure	Time frame
postprandial glucose and insulin level after the meal tolerance test, IMT, PWV	—

Countries

Japan

Contacts

Public ContactTsuyoshi Okura

Tottori University Faculty of Medicine Division of Cardiovascular Medicine, Endocrinology and Metabolism

ohkura@tottori-u.ac.jp0859386517

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026